About Mr. Velji
Rizwan Velji is a managing director based in William Blair’s New York office. He joined the firm's investment banking team in 2021. Prior to William Blair, he worked for Citigroup and Lazard.
- Karuna Therapeutics - initial public offering and follow on offerings
- PTC Therapeutics - follow on and convertible offerings
- Loxo Oncology - follow on offerings
- Apellis - initial public offering
- Gelesis - de-SPAC and PIPE financing
- Everest Medicines - initial public offering
- Sun Pharma - acqusition of Ranbaxy Holdings
- CRISPR Therapeutics - initial public offering
- Bristol Myers - acquisition of Amylin and Inhibitex
Independent and employee-owned
Companies Under Coverage
As of September 30, 2021
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.